0001437749-19-024638.txt : 20191218 0001437749-19-024638.hdr.sgml : 20191218 20191218210703 ACCESSION NUMBER: 0001437749-19-024638 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20191216 FILED AS OF DATE: 20191218 DATE AS OF CHANGE: 20191218 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Pellegrino Joseph P JR CENTRAL INDEX KEY: 0001365733 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33092 FILM NUMBER: 191293979 MAIL ADDRESS: STREET 1: 68 BEACON STREET CITY: BOSTON STATE: MA ZIP: 02108 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: LEMAITRE VASCULAR INC CENTRAL INDEX KEY: 0001158895 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 000000000 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 63 SECOND AVENUE CITY: BURLINGTON STATE: MA ZIP: 01803 BUSINESS PHONE: 781-221-2266 MAIL ADDRESS: STREET 1: 63 SECOND AVENUE CITY: BURLINGTON STATE: MA ZIP: 01803 4 1 rdgdoc.xml FORM 4 X0306 4 2019-12-16 0001158895 LEMAITRE VASCULAR INC LMAT 0001365733 Pellegrino Joseph P JR C/O LEMAITRE VASCULAR, INC. 63 SECOND AVENUE BURLINGTON MA 01803 1 1 Chief Financial Officer Common Stock 2019-12-16 4 S 0 6068 36.1742 D 41491 D Common Stock 2019-12-18 4 S 0 10442 36.09780 D 31049 D This transaction was effected pursuant to a Rule 10b5-1 trading plan established by the Reporting Person. The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $36.00 to $36.40. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected. The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $36.00 to $36.35. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected. /s/ Laurie A. Churchill, Attorney-in-fact 2019-12-18